Hamill Laura - Insider Non-Derivative Transactions at Y-mAbs Therapeutics, Inc. (YMAB) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Sep 16, 2025, Hamill Laura's relationship to Y-mAbs Therapeutics, Inc. (YMAB) is Director, and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other YMAB insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Hamill Laura - Insider Non-Derivative Transactions of YMAB Common Stock

Hamill Laura - Insider Non-Derivative Transactions at YMAB

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Sep 17, 2025	U -- (Common Stock)	5825	8.6	0
Sep 17, 2025	Disposition -- (Common Stock)	25080	0	0
Jul 1, 2025	Acquisition -- (Common Stock)	25080	0	30905
Jun 12, 2024	Acquisition -- (Common Stock)	3495	0	5825
Jun 9, 2023	Acquisition -- (Common Stock)	2330	0	2330